GalenusRx

The Florida Association of ACOs (FLAACOs) Fall Conference kicks off today, and we're in Orlando showing ACO teams a proven path to ADE prevention. If you're here, please stop by to see us in Booth 102. The average ACO can save significantly on medical expenditure just by addressing polypharmacy in attributed Medicare patients. And our APPRAISE platform lights the way there. You can also set up a time to meet—reach out to our team here: → https://lnkd.in/geW2qRzc #Medicare #ValueBasedCare #AccountableCare #Healthcare

Adverse drug event occurrence has doubled in the past decade, too. With ADEs happening more frequently and with more severity, patients and providers need answers—and proven solutions. APPRAISE? medication safety analytics is our way forward. Find out more: → https://galenusrx.com #Healthcare #HealthcareInnovation #Pharmaceutical #DrugSafety

In the U.S., we spend more to fix problems caused by prescription medications than we spend on medication itself. This problem doesn't get nearly enough attention—so we're addressing it, in conversation and through our medication safety platform, APPRAISE?. Learn more about medication safety management (and how we're working to improve it) by streaming our recent webinar "From Risk To Results: Managing Medication Safety in Value-Based Care": → https://lnkd.in/g_srufDg #DrugSafety #Healthcare #Pharmaceutical

"A data-driven approach to Pharmacovigilance holds immense promise and will pave the way for a more informed and holistic evaluation of drug safety, ultimately leading to safer and more effective treatments." This is what our medication safety analytics platform was built for. More about "How AI and NLP are Reshaping Pharmacovigilance" from RTInsights at the link below. If your organization is energized about reshaping pharmacovigilance, reach out. We'll introduce you to the promise of The APPRAISE?. #Pharmacovigilance #DrugSafety #Healthcare #Pharmaceutical

GalenusRx is exhibiting at this month's Florida Association of ACOs (FLAACOs) Fall Conference in Orlando. Visit us in Booth #116 to get a demonstration of APPRAISE?, our proven path to ADE prevention. If you'd like to set up a time to meet and learn more about our medication safety analytics, reach our team here: https://lnkd.in/geW2qRzc #ValueBasedCare #AccountableCare #HealthcareInnovation #Pharmaceutical

With #MedSafetyWeek going now through November 10, it feels like an opportune time to reshare this tool: 5 Moments for Medication Safety, developed by the World Health Organization. These are the key moments when action by patients and caregivers can significantly reduce the risk of adverse drug events. Each comes with key questions that guide those actions. ADEs are a rising global health concern, and turning that tide will require accurate, timely information. It's the foundation our medication safety platform was built on. Please save and share. Find the original here: https://lnkd.in/gKUfXgG3 #Pharmaceutical #HealthcareInnovation #PatientSafety

Estimates say that about half of adverse drug events are preventable. APPRAISE? ADE forecasting turns estimates into action. Learn more about how our platform benefits patients, providers, payers, and beyond: https://lnkd.in/gS6u2VwJ #HealthcareInnovation #PatientSafety #DrugSafety

Older adults may take 12+ medications for chronic conditions. But pre-approval drug-drug interaction (DDI) studies often miss the full complexity of real-world medication regimens and co-morbidities. GalenusRx's APPRAISE? augments standard DDI studies, using physiologically based pharmacokinetic modeling to predict multi-drug interactions. APPRAISE also enables comparative DDI risk assessments between a new drug and similar approved drugs. By demonstrating a superior safety profile, pharmaceutical companies can secure a competitive safety advantage that drives market acceptance and long-term profitability. Learn more about our proactive, predictive platform and how it improves the drug development process: → https://lnkd.in/gwTZrwHf #Pharmaceutical #Pharmacovigilance #HealthcareInnovation #PatientSafety

Appreciate the feedback from ACOs regarding the need for additional tools for medication safety to enhance outcomes. Thank you for visiting!

ADE risks rise with increased polypharmacy. It's why we developed APPRAISE?—to predict risk and improve outcomes for the large percentage of Americans taking multiple medications. Through Friday, we're at the National Association of ACOs' Fall 2024 Conference showing ACOs how our platform can help avoid millions in unnecessary spend. If you're here, come see us in Booth "S." You'll see exactly how the APPRAISE is revolutionizing medication safety with the power of precision. More here:? → https://lnkd.in/gKUs2QCC #HealthcareInnovation #ValueBasedCare #AccountableCare #PopulationHealth